GlassScriptPhysician profile
Charles Park
NPI 1861438517
$89,168.78
in general payments reported to CMS, 2019-2025
36 companies · $691 in 2025
The $691 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $4,729 · 2021: $30K · 2022: $15K · 2023: $4,582 · 2024: $9,992 · 2025: $691.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,250 · Food and Beverage: $4,408 · Travel and Lodging: $2,607.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,250.00 |
| Food and Beverage | $4,408.39 |
| Travel and Lodging | $2,606.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineology INC. | $83,713.08 | 2019-2024 | Optimesh Expandable Interbody Fusion System |
| Medtronic, INC. | $1,039.24 | 2021-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Unid_pass |
| Nevro Corp. | $719.65 | 2021-2024 | Senza |
| Providence Medical Technology, INC. | $676.90 | 2019-2025 | |
| Abbott Laboratories | $465.96 | 2022-2024 | Proclaim |
| Globus Medical, INC. | $305.45 | 2022-2023 | Excelsiusgps Robotic Navigation System |
| Medtronic USA, INC. | $274.10 | 2019-2020 | |
| Baxter Healthcare | $267.65 | 2019-2023 | Actifuse |
| Orthofix Medical, INC. | $227.02 | 2020-2023 | Physio-Stim, Spinal-Stim, Cervical-Stim |
| Ethicon US, LLC | $197.26 | 2022-2024 | Stratafix, Dermabond, Dermabond Prineo |
| Si-Bone, INC. | $193.42 | 2020-2022 | |
| Captiva Spine INC | $151.56 | 2024 | Transfasten Lsf |
| Stryker Corporation | $146.19 | 2019-2025 | Nico Brainpath Approach |
| Saluda Medical Americas, INC. | $117.28 | 2024 | Evoke |
| Integrity Implants INC. | $93.44 | 2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arteriocyte Medical Systems, INC. | $68.16 | 2022-2024 | Magellan |
| Depuy Synthes Sales INC. | $61.00 | 2022-2023 | Matrixneuro, Synthecel |
| Sanara Medtech INC. | $51.18 | 2022 | |
| Kuros Biosciences USA, INC | $47.58 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $39.63 | 2023 | Avitene Ultrafoam |
| Azurity Pharmaceuticals, INC. | $39.63 | 2023 | Triptodur, Gliadel |
| Lifenet Health | $33.44 | 2024 | Allograft Vmis Delivery System |
| Painteq LLC | $28.27 | 2024 | Painteq |
| Centinel Spine, LLC | $23.89 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $20.13 | 2023 | Andexxa |
| Native Surgical, LLC | $19.99 | 2025 | |
| Solventum Corporation | $19.61 | 2025 | Prevena |
| Portola Pharmaceuticals, LLC | $18.77 | 2019 | |
| Arbor Pharmaceuticals, INC. | $17.56 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $17.45 | 2019 | |
| Intrinsic Therapeutics | $16.06 | 2023 | Barricaid Acd (Annular Closure Device) |
| Stimwave Technologies Incorporated | $15.84 | 2019 | |
| Theragen, INC. | $15.00 | 2022 | |
| Misonix INC | $14.21 | 2021 | |
| Cerapedics INC. | $13.18 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$109,087.82 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.